ResMed Inc (RMD)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$242.33

Buy

$259.57

arrow-down$-0.12 (-0.05%)

Prices updated at 12 Dec 2025, 22:36 EST

Prices minimum 15 mins delay

Prices in USD

ResMed Inc is a part of the healthcare sector. It develops and distributes medical products for treating and diagnosing respiratory disorders.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Mr. Michael J. Farrell

CEO

Mr. Michael J. Farrell

Most recent earnings

30 Jun 2025

Fiscal year end

30 Jun 2025

Employees

10,600

Head office

9001 Spectrum Center Boulevard

San Diego

United States

92123

+1 858 836-5000

investorrelations@resmed.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Nicole Mowad-Nassar Independent Director	-
Dr. Peter C. Farrell, A.M.,PhD Director and Chairman Emeritus	0.07m
Mr. Ronald R. Taylor Lead Independent Director	0.11m
Mr. Brett A. Sandercock Chief Financial Officer and Principal Accounting Officer	0.50m
Mr. Michael J. Farrell Chairman of the Board and Chief Executive Officer	1.21m
Ms. Carol J. Burt Independent Director	0.11m
Ms. Karen Drexler Independent Director	0.09m
Ms. Harjit Gill Independent Director	0.07m
Mr. Jan De Witte Independent Director	0.07m
Mr. Justin Leong Chief Product Officer	0.68m
Mr. Christopher J. DelOrefice Independent Director	0.05m
Dr. John Hernandez Independent Director	0.07m
Dr. Desney Tan Independent Director	0.07m
Mr. Michael J. Rider Global General Counsel and Secretary	0.51m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	18,746,925
BlackRock Inc	12,277,966
State Street Corp	6,549,164
BlackRock Fund Advisors	5,588,058
Vanguard Investments Australia Ltd	4,697,113

Director dealings

Date chevron-l-regular chevron-r-regular	Action
09 Dec 2024	-
04 Dec 2024	-
02 Dec 2024	-
29 Nov 2024	-
25 Nov 2024	-
25 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-
22 Nov 2024	-
20 Nov 2024	-
20 Nov 2024	-
20 Nov 2024	-
20 Nov 2024	-
20 Nov 2024	-
20 Nov 2024	-
20 Nov 2024	-
20 Nov 2024	-
20 Nov 2024	-
20 Nov 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.